Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $71.2600 (0.87%) ($71.2600 - $71.2600) on Fri. Jan. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 65 | Latest Price | $71.2600(0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND advances 2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(48%) XBI(48%) IWC(47%) IWN(47%) IWO(46%) | Factors Impacting LGND price | LGND will decline at least -2.01% in a week (0% probabilities). VIXM(-24%) SHY(-17%) IGOV(-8%) EDOC(-6%) UUP(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $69.14(3.07%) | 10 Day Moving Average | $67.8(5.1%) | 20 Day Moving Average | $66.56(7.06%) | To recent high | -24.4% | To recent low | 15.3% | Market Cap | $1.145b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |